1998
DOI: 10.1002/art.1790110508
|View full text |Cite
|
Sign up to set email alerts
|

A survey of United States rheumatologists concerning effectiveness of disease‐modifying antirheumatic drugs and prednisone in the treatment of rheumatoid arthritis

Abstract: Objective. To collect the ratings of American rheumatologists regarding relative short-term and long-term effectiveness of disease-modifying antirheumatic drug(DMARD] therapyin the treatment of

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

1999
1999
2013
2013

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 18 publications
(12 reference statements)
1
2
0
Order By: Relevance
“…First, we chose not to send reminders and second mailings, in order to respect physicians' right to refuse participation, and as a result achieved a participation rate of 42.5%. This response rate, however, is consistent with (12,15) , or better than (16) , previous surveys of rheumatologists in the US. In addition, because the questionnaires were returned anonymously, we do not have any information on the non-responders.…”
Section: Discussionsupporting
confidence: 89%
“…First, we chose not to send reminders and second mailings, in order to respect physicians' right to refuse participation, and as a result achieved a participation rate of 42.5%. This response rate, however, is consistent with (12,15) , or better than (16) , previous surveys of rheumatologists in the US. In addition, because the questionnaires were returned anonymously, we do not have any information on the non-responders.…”
Section: Discussionsupporting
confidence: 89%
“…Chronic inflammation of the synovial membrane induces bone and cartilage destruction with erosions and joint space narrowing, which are partly related and worsen gradually over time (), predominantly during the first few years of the disease. In rheumatoid arthritis (RA), the rate of progression is highest during the first 2 years and most of the damage occurs within the first 5 years (). The goal of pharmacotherapy is to decrease both disease activity and joint progression.…”
Section: Introductionmentioning
confidence: 99%
“…Long-term observational studies are also used to evaluate therapies but these require investment in terms of time and money. A third approach, in addition to RCTs and long-term observation studies, is to survey rheumatologists regarding their opinions on newer therapies (Wolfe, Albert, & Pincus, 1998).…”
Section: Phase IImentioning
confidence: 99%